TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms.
Borbulevych, O.Y., Santhanagopolan, S.M., Hossain, M., Baker, B.M.(2011) J.Immunol. 187: 2453-2463
- PubMed: 21795600 
- DOI: 10.4049/jimmunol.1101268
- Primary Citation of Related Structures:  
- PubMed Abstract: 
T cells engineered to express TCRs specific for tumor Ags can drive cancer regression. The first TCRs used in cancer gene therapy, DMF4 and DMF5, recognize two structurally distinct peptide epitopes of the melanoma-associated MART-1/Melan-A protein, ...